Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
DC CAFC5 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.
63 Citations
11 Claims
- 1. A compound having the formula:
- 2. A compound having the formula:
- 3. A compound having the formula:
- 9. A compound having the formula:
Specification